Product Image

Contributor Information

  • Name Aymen Al-Shamkhani
  • Institute Absolute Antibody ; University of Southampton

Tool Details

  • Tool name: Anti-CD70 [TAN 1-7] rAb
  • Alternate names: CD7 Molecule; Tumor Necrosis Factor Ligand Superfamily Member 7; CD27 Ligand; CD27LG; TNFSF7; CD27L; Tumor Necrosis Factor Ligand 8A; Surface Antigen CD7; Ki-24 Antigen; CD7 Antigen; TNLG8A
  • Clone: TAN 1-7
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Recombinant
  • Conjugate: Unconjugated
  • Reactivity: Mouse
  • Host: Rat
  • Application: ELISA ; FACS ; IF ; Fn
  • Description: Recombinant monoclonal antibody directed against CD70 cytokine, capable of blocking the CD70-CD27 interaction involved in B and T cell activation. Background and Research Application CD70 is a cytokine that belongs to the tumour necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF27/CD27. It is a surface antigen on activated, but not on resting, T and B lymphocytes and dendritic cells. It induces proliferation of co-stimulated T cells, enhances the generation of cytolytic T cells, and contributes to T cell activation. This cytokine is also reported to play a role in regulating B cell activation, cytotoxic function of natural killer cells, and immunoglobulin synthesis. CD70 expression is induced upon activation of DCs, indicating that the CD70-CD27 interaction could take place during the activation of naive T cells by DCs. A recombinant version of anti-CD70, a non-depleting antibody which blocks the CD70-CD27 interaction. CD70 expression is thought to play a role in autoimmune disease regulation, and treatment of autoimmune diseases such as rheumatoid arthritis.
  • Immunogen: Recombinant mouse CD70 (extracellular domain, aa residues 41-195)
  • Immunogen UniProt ID: O55237
  • Isotype: IgG2a
  • Research area: Immunology

  • For Research Use Only

Target Details

  • Target: CD70
  • Target background: Recombinant monoclonal antibody directed against CD70 cytokine, capable of blocking the CD70-CD27 interaction involved in B and T cell activation. Background and Research Application CD70 is a cytokine that belongs to the tumour necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF27/CD27. It is a surface antigen on activated, but not on resting, T and B lymphocytes and dendritic cells. It induces proliferation of co-stimulated T cells, enhances the generation of cytolytic T cells, and contributes to T cell activation. This cytokine is also reported to play a role in regulating B cell activation, cytotoxic function of natural killer cells, and immunoglobulin synthesis. CD70 expression is induced upon activation of DCs, indicating that the CD70-CD27 interaction could take place during the activation of naive T cells by DCs. A recombinant version of a non-depleting antibody which blocks the CD70-CD27 interaction. CD70 expression is thought to play a role in autoimmune disease regulation, and treatment of autoimmune diseases such as rheumatoid arthritis.

Application Details

  • Application: ELISA ; FACS ; IF ; Fn

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Storage buffer: PBS
  • Storage conditions: Store at -20°C frozen. Avoid repeated freeze / thaw cycles
  • Shipping conditions: Shipping at 4°C

Documentation

Related Tools

Product Image

Anti-CEACAM5/6/8 (CD66e/c/b) [4H6-20]

#153321
Product Image

Anti-pTpY Cdk1 [CP3.2]

#151684
Product Image

Anti-Ricin B Chain [RBC11]

#154140

References

  • •  Original hybridoma first published in: Rowley et al. 2004. J Immunol. 172(10):6039-46. PMID: 15128787.